Literature DB >> 28647343

Alcoholic cardiomyopathy: What is known and what is not known.

Antonio Mirijello1, Claudia Tarli2, Gabriele Angelo Vassallo2, Luisa Sestito2, Mariangela Antonelli2, Cristina d'Angelo3, Anna Ferrulli2, Salvatore De Cosmo4, Antonio Gasbarrini2, Giovanni Addolorato2.   

Abstract

Excessive alcohol consumption represents one of the main causes of non-ischemic dilated cardiomyopathy. Alcoholic cardiomyopathy is characterized by dilation and impaired contraction of one or both myocardial ventricles. It represents the final effect of alcohol-induced toxicity to the heart. Several pathophysiological mechanisms have been proposed at the basis of alcohol-induced damage, most of which are still object of research. Unfortunately, symptoms of alcoholic cardiomyopathy are not specific and common to other forms of heart failure and appear when dilatation and systolic dysfunction are consolidated. Thus, early diagnosis is mandatory to prevent the development and progression to heart failure. Although physicians are aware of this disease, several pitfalls in the diagnosis, natural history, prognosis and treatment are still present. The aim of this narrative review is to describe clinical characteristics of alcoholic cardiomyopathy, highlighting the areas of uncertainty.
Copyright © 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AUD; Alcohol; Alcohol use disorder; Alcoholic cardiomyopathy; Ethanol

Mesh:

Year:  2017        PMID: 28647343     DOI: 10.1016/j.ejim.2017.06.014

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  19 in total

1.  The Impact of Substance Abuse on Heart Failure Hospitalizations.

Authors:  Marin Nishimura; Harpreet Bhatia; Janet Ma; Stephen D Dickson; Laith Alshawabkeh; Eric Adler; Alan Maisel; Michael H Criqui; Barry Greenberg; Isac C Thomas
Journal:  Am J Med       Date:  2019-07-29       Impact factor: 4.965

2.  Cardiovascular Consequences of Excessive Alcohol Drinking via Electrocardiogram: A Systematic Review.

Authors:  Lisa A Farinelli; Daria Piacentino; Brittney D Browning; Barbara B Brewer; Lorenzo Leggio
Journal:  J Addict Nurs       Date:  2021 Jan-Mar 01       Impact factor: 1.476

3.  Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies.

Authors:  Mehdi Farokhnia; Christopher T Rentsch; Vicky Chuong; M Adrienne McGinn; Sophie K Elvig; Eliza A Douglass; Luis A Gonzalez; Jenna E Sanfilippo; Renata C N Marchette; Brendan J Tunstall; David A Fiellin; George F Koob; Amy C Justice; Lorenzo Leggio; Leandro F Vendruscolo
Journal:  Mol Psychiatry       Date:  2022-09-20       Impact factor: 13.437

Review 4.  Extrahepatic Manifestations in Alcoholic Liver Disease.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2022-02-25

5.  Echocardiographic markers of early alcoholic cardiomyopathy: Six-month longitudinal study in heavy drinking patients.

Authors:  Antonio Mirijello; Luisa Sestito; Christian Lauria; Claudia Tarli; Gabriele Angelo Vassallo; Mariangela Antonelli; Cristina d'Angelo; Anna Ferrulli; Filippo Crea; Anthony Cossari; Lorenzo Leggio; Salvatore De Cosmo; Antonio Gasbarrini; Giovanni Addolorato
Journal:  Eur J Intern Med       Date:  2022-04-10       Impact factor: 7.749

6.  Nebivolol Prevents Up-Regulation of Nox2/NADPH Oxidase and Lipoperoxidation in the Early Stages of Ethanol-Induced Cardiac Toxicity.

Authors:  Gabriel T do Vale; Carla B P da Silva; Arthur H Sousa; Natália A Gonzaga; Juliana M Parente; Katiúscia M Araújo; Michele M Castro; Carlos R Tirapelli
Journal:  Cardiovasc Toxicol       Date:  2020-10-16       Impact factor: 3.231

Review 7.  Alcohol use disorders and the heart.

Authors:  Ed Day; James H F Rudd
Journal:  Addiction       Date:  2019-07-15       Impact factor: 6.526

8.  Risky Alcohol Consumption and Associated Health Behaviour Among HIV-Positive and HIV-Negative Patients in a UK Sexual Health and HIV Clinic: A Cross-Sectional Questionnaire Study.

Authors:  Emmi Suonpera; Rebecca Matthews; Ana Milinkovic; Alejandro Arenas-Pinto
Journal:  AIDS Behav       Date:  2020-06

Review 9.  The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy.

Authors:  Joaquim Fernández-Solà
Journal:  Nutrients       Date:  2020-02-22       Impact factor: 5.717

10.  Melatonin attenuates AFB1-induced cardiotoxicity via the NLRP3 signalling pathway.

Authors:  Hui Yan; Junhua Ge; Hongrui Gao; Yang Pan; Yan Hao; Jian Li
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.